Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label
publisher
tabling member	label

Search

1132113

	human indexable
	published
	registered interest
	answer date	18/06/2019
	date	13/06/2019
	date tabled	13/06/2019
	ddp created	13/06/2019 17:15:28
	answering body	Home Office
	question status	Tabled
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	ddp modified	13/06/2019 17:29:47 08/10/2019 16:41:18
	hansard heading	Disclosure and Barring Service
	house id	1
	identifier	264401
	legislature	25259
	parliament number	57
	question first answered	08/10/2019 16:09:06
	question text	To ask the Secretary of State for the Home Department, with reference to page 2 of the letter from the Cabinet Secretary of 10 April 2019 to the Public Accounts Committee inquiry on Disclosure and Barring Service: progress review, what estimate he has made of the increased cost to deliver modernisation as a result of the revision of the Full Business Case.
	session	2017/19
	session number	1
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	title	House of Commons Tabled Parliamentary Question 2017/19 264401
	type	WrittenParliamentaryQuestion
	uin	264401
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	4126 label Biography information for Mary Glindon
	publisher	25259
	tabling member	4126 label Biography information for Mary Glindon

1144466

	human indexable
	published
	registered interest
	answer date	09/09/2019
	date	03/09/2019
	date tabled	03/09/2019
	ddp created	03/09/2019 23:08:47
	answering body	Foreign and Commonwealth Office
	question status	Tabled
	answering dept id	16
	answering dept short name	Foreign and Commonwealth Office
	answering dept sort name	Foreign and Commonwealth Office
	ddp modified	03/09/2019 23:23:58 09/09/2019 14:42:04
	hansard heading	Iraq: Kurds
	house id	1
	identifier	286228
	legislature	25259
	parliament number	57
	question first answered	09/09/2019 14:10:33
	question text	To ask the Secretary of State for Foreign and Commonwealth Affairs, what assessment he has made of bilateral relations with the Kurdistan region in Iraq; and if he will make a statement.
	session	2017/19
	session number	1
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	title	House of Commons Tabled Parliamentary Question 2017/19 286228
	type	WrittenParliamentaryQuestion
	uin	286228
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	4126 label Biography information for Mary Glindon
	publisher	25259
	tabling member	4126 label Biography information for Mary Glindon

1144469

	human indexable
	published
	registered interest
	answer date	09/09/2019
	date	03/09/2019
	date tabled	03/09/2019
	ddp created	03/09/2019 23:08:54
	answering body	Home Office
	question status	Tabled
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	ddp modified	03/09/2019 23:24:05 09/09/2019 16:56:30
	hansard heading	Visas: Iraq
	house id	1
	identifier	286229
	legislature	25259
	parliament number	57
	question first answered	09/09/2019 16:23:34
	question text	To ask the Secretary of State for the Home Department, what plans she has to improve the visa application system in the Kurdistan Region of Iraq.
	session	2017/19
	session number	1
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	title	House of Commons Tabled Parliamentary Question 2017/19 286229
	type	WrittenParliamentaryQuestion
	uin	286229
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	4126 label Biography information for Mary Glindon
	publisher	25259
	tabling member	4126 label Biography information for Mary Glindon

1142923

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 17:46:31
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 17:56:10 09/09/2019 18:02:01
	hansard heading	NHS: Drugs
	house id	1
	identifier	284398
	legislature	25259
	parliament number	57
	question first answered	09/09/2019 17:30:47
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of scrapping Medicines Usage Reviews on people who take multiple medications.
	session	2017/19
	session number	1
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	title	House of Commons Tabled Parliamentary Question 2017/19 284398
	type	WrittenParliamentaryQuestion
	uin	284398
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4126 label Biography information for Mary Glindon
	publisher	25259
	tabling member	4126 label Biography information for Mary Glindon

1142924

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 17:46:37
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 17:56:12 09/09/2019 16:03:03
	hansard heading	NHS: Drugs
	house id	1
	identifier	284342
	legislature	25259
	parliament number	57
	question first answered	09/09/2019 15:31:26
	question text	To ask the Secretary of State for Health and Social Care, what alternative arrangements will be introduced in the new local pharmacy contract to safeguard people taking multiple medications and ensure they receive a regular review of their medication to prevent contraindications.
	session	2017/19
	session number	1
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	title	House of Commons Tabled Parliamentary Question 2017/19 284342
	type	WrittenParliamentaryQuestion
	uin	284342
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4126 label Biography information for Mary Glindon
	publisher	25259
	tabling member	4126 label Biography information for Mary Glindon

1142925

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 17:46:40
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 17:56:16 09/09/2019 19:26:04
	hansard heading	NHS: Staff
	house id	1
	identifier	284401
	legislature	25259
	parliament number	57
	question first answered	09/09/2019 18:54:26
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure specialist posts such as Parkinson’s nurses are included in the forthcoming NHS workforce plan.
	session	2017/19
	session number	1
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	title	House of Commons Tabled Parliamentary Question 2017/19 284401
	type	WrittenParliamentaryQuestion
	uin	284401
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4126 label Biography information for Mary Glindon
	publisher	25259
	tabling member	4126 label Biography information for Mary Glindon

1142926

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 17:46:43
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 17:56:19 09/09/2019 19:26:02
	hansard heading	NHS: Vacancies
	house id	1
	identifier	284346
	legislature	25259
	parliament number	57
	question first answered	09/09/2019 18:54:26
	question text	To ask the Secretary of State for Health and Social Care, what steps the NHS will take as part of the forthcoming NHS workforce plan to minimise the vacancy rates of (a) Parkinson’s nurses and (b) other specialist posts.
	session	2017/19
	session number	1
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	title	House of Commons Tabled Parliamentary Question 2017/19 284346
	type	WrittenParliamentaryQuestion
	uin	284346
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4126 label Biography information for Mary Glindon
	publisher	25259
	tabling member	4126 label Biography information for Mary Glindon

1143006

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 17:59:14
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 18:07:08 09/09/2019 15:49:05
	hansard heading	NHS: Drugs
	house id	1
	identifier	284562
	legislature	25259
	parliament number	57
	question first answered	09/09/2019 15:17:11
	question text	To ask the Secretary of State for Health and Social Care, how many Medicines Usage Reviews have taken place in each year since their introduction.
	session	2017/19
	session number	1
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	title	House of Commons Tabled Parliamentary Question 2017/19 284562
	type	WrittenParliamentaryQuestion
	uin	284562
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4126 label Biography information for Mary Glindon
	publisher	25259
	tabling member	4126 label Biography information for Mary Glindon

1143007

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 17:59:18
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 18:07:12 09/09/2019 15:46:03
	hansard heading	Parkinson's Disease: Drugs
	house id	1
	identifier	284564
	legislature	25259
	parliament number	57
	question first answered	09/09/2019 15:14:49
	question text	To ask the Secretary of State for Health and Social Care, how many Medicines Usage Reviews have been undertaken for people with Parkinson's in each year since their introduction.
	session	2017/19
	session number	1
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	title	House of Commons Tabled Parliamentary Question 2017/19 284564
	type	WrittenParliamentaryQuestion
	uin	284564
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4126 label Biography information for Mary Glindon
	publisher	25259
	tabling member	4126 label Biography information for Mary Glindon

1143008

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 17:59:22
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 18:07:16 09/09/2019 15:58:11
	hansard heading	NHS: Drugs
	house id	1
	identifier	284565
	legislature	25259
	parliament number	57
	question first answered	09/09/2019 15:26:16
	question text	To ask the Secretary of State for Health and Social Care, if he will publish the impact assessment for Medicines Usage Reviews not being included in the new community pharmacy contract.
	session	2017/19
	session number	1
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	title	House of Commons Tabled Parliamentary Question 2017/19 284565
	type	WrittenParliamentaryQuestion
	uin	284565
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4126 label Biography information for Mary Glindon
	publisher	25259
	tabling member	4126 label Biography information for Mary Glindon